9/6/2012 10:43:11 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that management will meet with investors and make presentations at the Rodman & Renshaw Annual Global Investment Conference, at the ThinkEquity 9th Annual Growth Conference and at the Burrill Personalized Medicine Meeting. Investors and the public are invited to listen to live webcasts of the presentations listed below. Following the conference, these webcasts will be archived for approximately 30 days.
comments powered by